GLA and metabolic disease: Fabry disease is a rare multisystem metabolic disease resulting from multiple types of mutations in the GLA gene that cause deficiency of the lysosomal enzyme alpha-galactosidase A, resulting in accumulation of glycosphingolipids, particularly globotriaosylceramide, in the lysosomes leads to (GL3) (98, 100, 101).